Back to top
more

aTyr Pharma (LIFE)

(Delayed Data from NSDQ)

$NA USD

NA
NA

0 (0.00%)

Updated Dec 31, 1969 06:00 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.08%
2Buy17.91%
3Hold9.44%
4Sell5.10%
5Strong Sell2.55%
S&P50011.04%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 34% (84 out of 248)

Industry: Medical - Biomedical and Genetics

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Brokerage Reports

1 item in cart

View Cart/Checkout

[LIFE]

Reports for Purchase

Showing records 161 - 174 ( 174 total )

Industry: Medical - Products

Record: 161

02/04/2011

Company Report

Pages: 5

In-line Q4 despite tough comps; Increasing PT to $63

Provider: AURIGA USA

Analyst: MEHRA R

Price: 10.00

Research Provided by a Third Party

Industry: Medical - Products

Record: 162

11/12/2010

Company Report

Pages: 6

Post-Quarter Odds and Ends - BGI, ASHG, and Ion Torrent

Provider: AURIGA USA

Analyst: MEHRA R

Price: 25.00

Research Provided by a Third Party

Industry: Medical - Products

Record: 163

11/11/2010

Company Report

Pages: 10

Price: 24.95

Industry: Medical - Products

Record: 164

10/27/2010

Company Report

Pages: 5

3Q10 Results Review: Hurdles? What Hurdles?

Provider: AURIGA USA

Analyst: MEHRA R

Price: 10.00

Research Provided by a Third Party

Industry: Medical - Products

Record: 165

10/25/2010

Daily Note

Pages: 6

3Q10 Earnings Preview: Likely Steady As She Goes.

Provider: AURIGA USA

Analyst: MCDONALD P

Price: 25.00

Research Provided by a Third Party

Industry: Medical - Products

Record: 166

08/18/2010

Company Report

Pages: 4

Bridging the Gap in Sequencing

Provider: AURIGA USA

Analyst: MEHRA R

Price: 10.00

Research Provided by a Third Party

Industry: Medical - Products

Record: 167

08/12/2010

Company Report

Pages: 10

Price: 24.95

Industry: Medical - Products

Record: 168

07/30/2010

Company Report

Pages: 5

2Q10 Results: Generally Positive, but Tough Comps Mask Positive 2H Outlook

Provider: AURIGA USA

Analyst: MEHRA R

Price: 10.00

Research Provided by a Third Party

Industry: Medical - Products

Record: 169

06/23/2010

Company Report

Pages: 8

Price: 24.95

Industry: Medical - Products

Record: 170

06/03/2010

Company Report

Pages: 5

LIFE Investor Day Review: Lots of Growing Pieces.

Provider: AURIGA USA

Price: 10.00

Research Provided by a Third Party

Industry: Medical - Products

Record: 171

04/28/2010

Company Report

Pages: 5

Strong Quarter, Reiterating Buy

Provider: AURIGA USA

Price: 10.00

Research Provided by a Third Party

Industry: Medical - Products

Record: 172

03/17/2010

Company Report

Pages: 8

Price: 24.95

Industry: Medical - Products

Record: 173

01/28/2010

Company Report

Pages: 6

Solid Q4 and 2010 guidance.

Provider: AURIGA USA

Price: 25.00

Research Provided by a Third Party

Industry: Medical - Products

Record: 174

01/04/2010

Company Report

Pages: 7

Price: 24.95